Psilocybin

Home Office written question – answered on 24th January 2023.

Alert me about debates like this

Photo of Crispin Blunt Crispin Blunt Conservative, Reigate

To ask the Secretary of State for the Home Department, if he will hold discussions with the Chief Medical Officer on the potential merits of psilocybin's (a) medicinal and (b) therapeutic use.

Photo of Chris Philp Chris Philp The Minister of State, Home Department

There are no current plans for a meeting between Home Office Ministers and the Chief Medical Officer for England on the topic of psilocybin.

There is an established process for the development of medicines, overseen by the Medicines and Healthcare products Regulatory Agency (MHRA), which enables medicines (including those containing Schedule 1 controlled drugs such as psilocybin) to be developed, evaluated in clinical trials and licensed based on an assessment of their safety, quality and efficacy before being made available to patients in the UK. Should an application be submitted for a marketing authorisation (product licence), it will ultimately be a decision for the MHRA whether to license psilocybin as a therapy.

In the context of these arrangements, officials from Department of Health and Social Care and the Home Office liaise regularly on matters connected to controlled drugs in healthcare to inform advice to Ministers. The views of experts including the Chief Medical Officer can be taken into account as part of this process.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.